Dr. Sharma has held several senior management positions managing operations, corporate development and executive management within the pharmaceuticals and chemicals industries.
He is a Senior Advisor focused on Asia pharma opportunities at The Carlyle Group, one of the world’s largest and most diversified global investment firms, with $376 billion of assets under management across three business segments and 520 investment vehicles.
He is also the Non-Executive Vice-Chairman of Lupin. As its Managing Director (2003 to 2013) and a member of its senior management team for over three decades, Dr. Sharma was one of the architects of Lupin achieving market leadership in key markets and businesses globally, transforming it into one of the largest and fastest growing pharmaceutical companies globally.
Dr. Sharma also served as the President and Chief Executive of the life sciences and speciality group and was a member of the management board at RPG Enterprises Ltd, Mumbai.
Dr. Sharma is a chemical engineer from the Indian Institute of Technology (IIT), Kanpur, with a post-graduate diploma in industrial management from Jamnalal Bajaj Institute of Management Studies, Mumbai, and a PhD in economics from IIT, Mumbai. He also holds an advanced management degree from Harvard Business School, Boston.